Neglected tropical diseases: non-profits lead the way as private sectors lags
The Covid-19 pandemic has put extra pressure on research for neglected tropical diseases, but developments continue
By
The Covid-19 pandemic has put extra pressure on research for neglected tropical diseases, but developments continue
ByGemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
The filing is based on data from six clinical trials in subjects of the age 18 years and above.
The latest approval is based on findings from the Phase II ZUMA-5 trial in 122 relapsed or refractory FL patients.
Sutro could be eligible for milestone payments of up to $422.5m for each product candidate.
The latest development is based on findings from the global Phase III OlympiA trial of Lynparza.
Seven of the ten hepatitis C therapies analysed were found to suppress the SARS-CoV-2 virus.
Thank you for subscribing to Pharmaceutical Technology